Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Cell Cycle (Georgetown, Tex.)|March 14, 2014
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53Sara M Reed, Jussara Hagen, Van S Tompkins, et al.
Cancers|December 30, 2014
p53 Acetylation: Regulation and ConsequencesSara M Reed, Dawn E Quelle
Molecular and Cellular Biology|February 3, 2005
Nucleophosmin (B23) targets ARF to nucleoli and inhibits its functionChandrashekhar Korgaonkar, Jussara Hagen, Van Tompkins, et al.
Immunologic Research|October 6, 2007
Cytokine signaling to the cell cycleFrederick W Quelle
Molecular Cancer Research : MCR|August 13, 2009
FOXO transcription factors enforce cell cycle checkpoints and promote survival of hematopoietic cells after DNA damageHong Lei, Frederick W Quelle
Cell Cycle (Georgetown, Tex.)|September 5, 2008
Phosphoinositide 3-kinase signaling overrides a G2 phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damageDipali Nimbalkar, Frederick W Quelle
International Journal of Molecular Sciences|September 9, 2023
FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor TherapyEllen Voigt, Dawn E Quelle
Cancer Research|October 3, 2014
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent mannerJussara Hagen, Viviane P Muniz, Kelly C Falls, et al.
Oncotarget|September 30, 2024
Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumorsJoshua J Lingo, Ellen Voigt, Dawn E Quelle
The Journal of Biological Chemistry|May 15, 2003
Erythropoietin receptors associate with a ubiquitin ligase, p33RUL, and require its activity for erythropoietin-induced proliferationAnn D Friedman, Dipali Nimbalkar, Frederick W Quelle
Pageof 8